 Anis Karimpour-Fard
Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 9 | 2015 | 530 | 1.010 |
Why?
| | MicroRNAs | 9 | 2023 | 600 | 0.930 |
Why?
| | Cardiomyopathy, Dilated | 6 | 2023 | 348 | 0.720 |
Why?
| | Software | 2 | 2015 | 530 | 0.650 |
Why?
| | Protein Interaction Mapping | 3 | 2008 | 101 | 0.640 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 24 | 0.520 |
Why?
| | Proteomics | 6 | 2015 | 837 | 0.500 |
Why?
| | DNA Copy Number Variations | 2 | 2018 | 154 | 0.480 |
Why?
| | Hibernation | 5 | 2014 | 72 | 0.470 |
Why?
| | Phylogeny | 4 | 2014 | 789 | 0.430 |
Why?
| | Ventricular Remodeling | 3 | 2021 | 226 | 0.420 |
Why?
| | Gene Expression Profiling | 10 | 2021 | 1518 | 0.400 |
Why?
| | Myocytes, Cardiac | 4 | 2021 | 449 | 0.400 |
Why?
| | Comparative Genomic Hybridization | 2 | 2018 | 28 | 0.400 |
Why?
| | Escherichia coli | 6 | 2012 | 720 | 0.390 |
Why?
| | Sciuridae | 5 | 2014 | 142 | 0.380 |
Why?
| | Proteome | 3 | 2023 | 340 | 0.340 |
Why?
| | Multigene Family | 3 | 2008 | 190 | 0.320 |
Why?
| | Cluster Analysis | 6 | 2021 | 455 | 0.320 |
Why?
| | Seasons | 5 | 2014 | 442 | 0.300 |
Why?
| | MAP Kinase Kinase Kinases | 2 | 2021 | 68 | 0.300 |
Why?
| | Sequence Analysis, Protein | 1 | 2007 | 27 | 0.290 |
Why?
| | Data Collection | 1 | 2010 | 620 | 0.290 |
Why?
| | Superoxide Dismutase | 2 | 2020 | 306 | 0.290 |
Why?
| | DNA Helicases | 2 | 2021 | 133 | 0.280 |
Why?
| | Gammaproteobacteria | 1 | 2007 | 13 | 0.280 |
Why?
| | Algorithms | 3 | 2008 | 1470 | 0.280 |
Why?
| | Metabolic Networks and Pathways | 5 | 2017 | 168 | 0.280 |
Why?
| | Bacterial Proteins | 2 | 2010 | 736 | 0.270 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2012 | 740 | 0.270 |
Why?
| | Signal Transduction | 4 | 2023 | 4517 | 0.260 |
Why?
| | Genome, Bacterial | 4 | 2012 | 106 | 0.260 |
Why?
| | Genome | 4 | 2014 | 271 | 0.240 |
Why?
| | Escherichia coli Proteins | 3 | 2012 | 162 | 0.240 |
Why?
| | Biomarkers | 6 | 2022 | 3408 | 0.230 |
Why?
| | Models, Biological | 2 | 2008 | 1621 | 0.230 |
Why?
| | Heart Defects, Congenital | 2 | 2021 | 670 | 0.210 |
Why?
| | Transcriptome | 4 | 2021 | 726 | 0.210 |
Why?
| | Heart Failure | 3 | 2023 | 1945 | 0.210 |
Why?
| | Arousal | 3 | 2012 | 152 | 0.210 |
Why?
| | DNA-Binding Proteins | 3 | 2021 | 1314 | 0.210 |
Why?
| | Perforator Flap | 1 | 2022 | 22 | 0.200 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 121 | 0.190 |
Why?
| | Species Specificity | 6 | 2008 | 542 | 0.190 |
Why?
| | Bleomycin | 2 | 2020 | 228 | 0.190 |
Why?
| | Focal Adhesions | 1 | 2021 | 42 | 0.190 |
Why?
| | Prostatic Neoplasms | 2 | 2021 | 921 | 0.190 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 21 | 0.190 |
Why?
| | Amniotic Fluid | 1 | 2021 | 64 | 0.180 |
Why?
| | Genetic Variation | 4 | 2018 | 870 | 0.180 |
Why?
| | Mammaplasty | 1 | 2022 | 68 | 0.180 |
Why?
| | Hypotension | 1 | 2022 | 116 | 0.180 |
Why?
| | Milrinone | 1 | 2021 | 24 | 0.180 |
Why?
| | Biological Products | 1 | 2023 | 166 | 0.180 |
Why?
| | Heart Transplantation | 2 | 2018 | 665 | 0.180 |
Why?
| | Phosphorylation | 3 | 2021 | 1569 | 0.180 |
Why?
| | Evolution, Molecular | 4 | 2014 | 430 | 0.170 |
Why?
| | Receptors, Androgen | 1 | 2021 | 131 | 0.170 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 206 | 0.170 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 76 | 0.160 |
Why?
| | Myocardium | 2 | 2017 | 913 | 0.160 |
Why?
| | Animals | 23 | 2023 | 31710 | 0.160 |
Why?
| | RNA Interference | 1 | 2021 | 433 | 0.160 |
Why?
| | Chromatography, Liquid | 3 | 2016 | 347 | 0.160 |
Why?
| | Keloid | 1 | 2019 | 7 | 0.160 |
Why?
| | Dermis | 1 | 2019 | 30 | 0.160 |
Why?
| | Inflammation | 2 | 2020 | 2480 | 0.160 |
Why?
| | Fever | 1 | 2020 | 280 | 0.160 |
Why?
| | Ovarian Neoplasms | 1 | 2023 | 388 | 0.160 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 22 | 0.150 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2320 | 0.150 |
Why?
| | Mosaicism | 1 | 2018 | 61 | 0.150 |
Why?
| | Fluorouracil | 1 | 2019 | 152 | 0.150 |
Why?
| | Extracellular Matrix | 1 | 2021 | 436 | 0.150 |
Why?
| | Cardiomyopathies | 1 | 2021 | 298 | 0.150 |
Why?
| | Humans | 32 | 2023 | 114711 | 0.150 |
Why?
| | Serum | 1 | 2018 | 57 | 0.140 |
Why?
| | Heart Ventricles | 2 | 2021 | 712 | 0.140 |
Why?
| | Databases, Genetic | 2 | 2015 | 206 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2020 | 299 | 0.140 |
Why?
| | Specimen Handling | 1 | 2018 | 156 | 0.140 |
Why?
| | Energy Metabolism | 3 | 2023 | 731 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 250 | 0.130 |
Why?
| | Reference Values | 2 | 2008 | 743 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 412 | 0.130 |
Why?
| | RNA, Messenger | 5 | 2021 | 2553 | 0.130 |
Why?
| | Models, Genetic | 3 | 2008 | 562 | 0.130 |
Why?
| | Plasma | 1 | 2018 | 211 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 314 | 0.130 |
Why?
| | Ethanol | 2 | 2012 | 538 | 0.120 |
Why?
| | Calcium | 1 | 2021 | 1108 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2018 | 498 | 0.120 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2017 | 287 | 0.120 |
Why?
| | Karyotype | 1 | 2014 | 13 | 0.120 |
Why?
| | Hylobates | 1 | 2014 | 8 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 1880 | 0.120 |
Why?
| | Fetus | 1 | 2018 | 700 | 0.120 |
Why?
| | Female | 20 | 2023 | 59573 | 0.110 |
Why?
| | Down-Regulation | 2 | 2021 | 594 | 0.110 |
Why?
| | Metabolomics | 2 | 2016 | 521 | 0.110 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2014 | 109 | 0.110 |
Why?
| | Heart | 2 | 2021 | 612 | 0.110 |
Why?
| | Mutation | 5 | 2023 | 3346 | 0.110 |
Why?
| | Amino Acids | 1 | 2016 | 448 | 0.100 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 21 | 0.100 |
Why?
| | Biomarkers, Tumor | 2 | 2023 | 1040 | 0.100 |
Why?
| | Fasting | 1 | 2014 | 241 | 0.100 |
Why?
| | Drug Tolerance | 1 | 2012 | 79 | 0.100 |
Why?
| | Lipectomy | 1 | 2012 | 7 | 0.100 |
Why?
| | Dog Diseases | 1 | 2012 | 41 | 0.100 |
Why?
| | Breast Neoplasms | 2 | 2022 | 1862 | 0.100 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 607 | 0.100 |
Why?
| | Subcutaneous Fat | 1 | 2012 | 70 | 0.100 |
Why?
| | Abdomen | 1 | 2012 | 99 | 0.100 |
Why?
| | Ventricular Function, Left | 1 | 2015 | 467 | 0.100 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 86 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2016 | 688 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 159 | 0.090 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2011 | 45 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2018 | 2766 | 0.090 |
Why?
| | Gluconeogenesis | 1 | 2011 | 62 | 0.090 |
Why?
| | Recovery of Function | 1 | 2015 | 574 | 0.090 |
Why?
| | Male | 16 | 2021 | 55669 | 0.090 |
Why?
| | Gene Duplication | 3 | 2007 | 62 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2012 | 218 | 0.090 |
Why?
| | Mice | 8 | 2023 | 14872 | 0.090 |
Why?
| | Child | 8 | 2022 | 18423 | 0.090 |
Why?
| | Gene Dosage | 2 | 2010 | 129 | 0.090 |
Why?
| | Ligases | 1 | 2010 | 30 | 0.090 |
Why?
| | Sigma Factor | 1 | 2010 | 33 | 0.090 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 228 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 231 | 0.090 |
Why?
| | Glycolysis | 1 | 2011 | 227 | 0.090 |
Why?
| | Pancreas | 1 | 2012 | 276 | 0.090 |
Why?
| | Markov Chains | 1 | 2010 | 114 | 0.090 |
Why?
| | Muscle Proteins | 1 | 2011 | 210 | 0.080 |
Why?
| | Recombination, Genetic | 1 | 2010 | 176 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2023 | 2711 | 0.080 |
Why?
| | Oligonucleotides | 1 | 2010 | 137 | 0.080 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 430 | 0.080 |
Why?
| | Phenotype | 2 | 2023 | 2797 | 0.080 |
Why?
| | Case-Control Studies | 3 | 2021 | 3004 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2023 | 1950 | 0.080 |
Why?
| | DNA Repair | 1 | 2010 | 184 | 0.080 |
Why?
| | Escherichia coli K12 | 1 | 2008 | 7 | 0.080 |
Why?
| | Genetic Enhancement | 1 | 2008 | 6 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 610 | 0.080 |
Why?
| | Biostatistics | 1 | 2008 | 15 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2021 | 778 | 0.070 |
Why?
| | Genomics | 1 | 2012 | 635 | 0.070 |
Why?
| | Adiposity | 1 | 2012 | 458 | 0.070 |
Why?
| | Computer Simulation | 2 | 2008 | 873 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 801 | 0.070 |
Why?
| | Pneumonia | 1 | 2012 | 568 | 0.070 |
Why?
| | Protein Engineering | 1 | 2008 | 98 | 0.070 |
Why?
| | Chromosome Mapping | 1 | 2008 | 487 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 353 | 0.070 |
Why?
| | Shigella flexneri | 1 | 2007 | 11 | 0.070 |
Why?
| | Macaca mulatta | 1 | 2007 | 131 | 0.070 |
Why?
| | Databases, Protein | 1 | 2007 | 59 | 0.070 |
Why?
| | Likelihood Functions | 1 | 2007 | 126 | 0.070 |
Why?
| | Primates | 1 | 2007 | 111 | 0.070 |
Why?
| | Models, Statistical | 2 | 2008 | 599 | 0.070 |
Why?
| | DNA Probes | 1 | 2006 | 59 | 0.070 |
Why?
| | Liver | 1 | 2014 | 1637 | 0.070 |
Why?
| | Forecasting | 1 | 2007 | 330 | 0.060 |
Why?
| | Kidney | 1 | 2012 | 1188 | 0.060 |
Why?
| | Genome, Human | 1 | 2007 | 347 | 0.060 |
Why?
| | Child, Preschool | 4 | 2021 | 9119 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2018 | 3886 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2219 | 0.060 |
Why?
| | Prospective Studies | 3 | 2022 | 6220 | 0.060 |
Why?
| | Biofilms | 1 | 2007 | 223 | 0.060 |
Why?
| | Sequence Analysis, DNA | 4 | 2010 | 723 | 0.060 |
Why?
| | Echocardiography | 2 | 2021 | 553 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1036 | 0.060 |
Why?
| | Models, Theoretical | 1 | 2007 | 515 | 0.060 |
Why?
| | Phosphoproteins | 2 | 2019 | 298 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 35 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 1796 | 0.050 |
Why?
| | Rats | 2 | 2021 | 4959 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2014 | 100 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2021 | 388 | 0.050 |
Why?
| | Sarcomeres | 1 | 2023 | 90 | 0.050 |
Why?
| | Up-Regulation | 2 | 2018 | 808 | 0.050 |
Why?
| | Epigastric Arteries | 1 | 2022 | 18 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1473 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1143 | 0.050 |
Why?
| | Endopeptidase K | 1 | 2021 | 14 | 0.050 |
Why?
| | Ribonucleases | 1 | 2021 | 52 | 0.050 |
Why?
| | Light Coagulation | 1 | 2021 | 7 | 0.050 |
Why?
| | Bacteria | 1 | 2007 | 725 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2785 | 0.050 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 37 | 0.050 |
Why?
| | Fetoscopy | 1 | 2021 | 28 | 0.050 |
Why?
| | Serum Response Factor | 1 | 2021 | 29 | 0.050 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 40 | 0.050 |
Why?
| | Body Temperature | 2 | 2012 | 208 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 113 | 0.050 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 49 | 0.050 |
Why?
| | Infant | 3 | 2020 | 7969 | 0.040 |
Why?
| | DNA Primers | 2 | 2012 | 510 | 0.040 |
Why?
| | Cardiac Output, Low | 1 | 2021 | 64 | 0.040 |
Why?
| | Drainage | 1 | 2021 | 151 | 0.040 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 6 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 149 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1147 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 169 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 41 | 0.040 |
Why?
| | Cardiotonic Agents | 1 | 2021 | 119 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 236 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 236 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2020 | 109 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 167 | 0.040 |
Why?
| | Hominidae | 2 | 2014 | 79 | 0.040 |
Why?
| | Mass Spectrometry | 2 | 2014 | 633 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 122 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2019 | 32 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 591 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 386 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2012 | 1226 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2019 | 105 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 4895 | 0.040 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 36 | 0.040 |
Why?
| | Pregnancy | 2 | 2021 | 5520 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 542 | 0.040 |
Why?
| | Transcription Factors | 2 | 2019 | 1528 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 4694 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1629 | 0.040 |
Why?
| | Pilot Projects | 1 | 2022 | 1373 | 0.040 |
Why?
| | Freezing | 1 | 2018 | 84 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 372 | 0.040 |
Why?
| | Critical Illness | 1 | 2022 | 645 | 0.040 |
Why?
| | Adult | 4 | 2021 | 30562 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 638 | 0.030 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 7 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 39 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 76 | 0.030 |
Why?
| | Lectins, C-Type | 1 | 2016 | 61 | 0.030 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2016 | 20 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 923 | 0.030 |
Why?
| | Risk Factors | 2 | 2021 | 8634 | 0.030 |
Why?
| | Granzymes | 1 | 2016 | 40 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 367 | 0.030 |
Why?
| | Hot Temperature | 1 | 2018 | 302 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 1841 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 195 | 0.030 |
Why?
| | Prognosis | 2 | 2015 | 3330 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 935 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 859 | 0.030 |
Why?
| | Pan troglodytes | 2 | 2007 | 47 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2637 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 2007 | 187 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 17856 | 0.030 |
Why?
| | Chemokines | 1 | 2016 | 216 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 152 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1760 | 0.030 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 12 | 0.030 |
Why?
| | Retroelements | 1 | 2014 | 39 | 0.030 |
Why?
| | Immunologic Memory | 1 | 2016 | 313 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 242 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 504 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2187 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2016 | 419 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 12558 | 0.030 |
Why?
| | Cadherins | 1 | 2015 | 175 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2540 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 442 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 442 | 0.030 |
Why?
| | Lung | 2 | 2018 | 3561 | 0.030 |
Why?
| | Acetylation | 1 | 2014 | 211 | 0.030 |
Why?
| | Sirtuin 3 | 1 | 2014 | 52 | 0.030 |
Why?
| | Mycoplasma pneumoniae | 1 | 2012 | 28 | 0.030 |
Why?
| | CD146 Antigen | 1 | 2012 | 35 | 0.030 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2012 | 30 | 0.030 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2012 | 12 | 0.030 |
Why?
| | Bacterial Load | 1 | 2012 | 58 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2012 | 84 | 0.030 |
Why?
| | Selection, Genetic | 1 | 2014 | 242 | 0.030 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 80 | 0.030 |
Why?
| | Peptide Library | 1 | 2012 | 81 | 0.030 |
Why?
| | Young Adult | 2 | 2021 | 10472 | 0.030 |
Why?
| | Skinfold Thickness | 1 | 2012 | 49 | 0.020 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.020 |
Why?
| | Body Fat Distribution | 1 | 2012 | 46 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 110 | 0.020 |
Why?
| | Cystathionine beta-Synthase | 1 | 2012 | 59 | 0.020 |
Why?
| | Receptors, Complement 3b | 1 | 2012 | 81 | 0.020 |
Why?
| | Adenoviridae | 1 | 2012 | 184 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 292 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2012 | 147 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 274 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 334 | 0.020 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2012 | 102 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2011 | 43 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 137 | 0.020 |
Why?
| | Thermogenesis | 1 | 2011 | 37 | 0.020 |
Why?
| | Exons | 1 | 2012 | 302 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 620 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2011 | 113 | 0.020 |
Why?
| | Hindlimb | 1 | 2011 | 130 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3535 | 0.020 |
Why?
| | Glycine | 1 | 2011 | 152 | 0.020 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 17 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2010 | 20 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 107 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4411 | 0.020 |
Why?
| | Arginine | 1 | 2011 | 238 | 0.020 |
Why?
| | Gene Library | 1 | 2010 | 114 | 0.020 |
Why?
| | NAD | 1 | 2010 | 63 | 0.020 |
Why?
| | Middle Aged | 3 | 2017 | 26740 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2010 | 80 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 477 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 348 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 760 | 0.020 |
Why?
| | Genes | 1 | 2010 | 223 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 1701 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 385 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 641 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 463 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 356 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 444 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 275 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2382 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2010 | 285 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2363 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2008 | 109 | 0.020 |
Why?
| | Radiographic Image Enhancement | 1 | 2008 | 52 | 0.020 |
Why?
| | Neutrophils | 1 | 2012 | 1176 | 0.020 |
Why?
| | Mammography | 1 | 2008 | 105 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 923 | 0.020 |
Why?
| | Genetic Diseases, Inborn | 1 | 2007 | 36 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2114 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1177 | 0.020 |
Why?
| | Gene Rearrangement | 1 | 2007 | 135 | 0.020 |
Why?
| | Heat-Shock Response | 1 | 2006 | 46 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9089 | 0.020 |
Why?
| | Cytokines | 1 | 2012 | 1841 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2006 | 312 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2004 | 16 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 2004 | 6 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2004 | 18 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 993 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 2894 | 0.010 |
Why?
| | Environment | 1 | 2006 | 332 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2004 | 104 | 0.010 |
Why?
| | Quantitative Trait Loci | 1 | 2006 | 305 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 256 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2004 | 309 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2004 | 522 | 0.010 |
Why?
| | Biomedical Research | 1 | 2007 | 585 | 0.010 |
Why?
| | Sleep | 1 | 2006 | 632 | 0.010 |
Why?
| | Biological Evolution | 1 | 2004 | 416 | 0.010 |
Why?
| | Alcoholism | 1 | 2006 | 713 | 0.010 |
Why?
| | Proteins | 1 | 2004 | 908 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 6114 | 0.010 |
Why?
|
|
Karimpour-Fard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|